Rosetta Genomics Ltd (NASDAQ:ROSG)

3.51
Delayed Data
As of 3:59pm ET
 -0.05 / -1.40%
Today’s Change
2.07
Today|||52-Week Range
6.69
+55.31%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2010
Quarter 4
2010
Quarter 1
2011
Quarter 2
2011
Revenue and IncomeNet Revenues136.0K45.0K37.0K22.0K
 
 
 
 
 
Cost of Goods Sold172.0K158.0K124.0K65.0K
 
 
 
 
 
 
Operating ExpensesGross Income-36.0K-113.0K-87.0K-43.0K
 
 
 
 
 
General Expenses3.4M3.4M2.5M3.2M
 
 
 
 
 
Other Operating Expenses554.0K0.000.000.00
 
 
Research And Development1.7M1.2M1.0M1.3M
 
 
 
 
 
Total Operating Expenses4.2M3.6M2.6M3.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.0M-3.6M-2.6M-3.2M
 
 
 
 
 
Interest Expense On Debt--28.0K----
 
 
Other Expenses544.0K0.00822.0K421.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.5M-3.6M-1.8M-2.8M
 
 
 
 
 
Minority Interest-99.0K-69.0K-96.0K-261.0K
 
 
 
 
 
Discontinued Operations0.00-158.0K0.000.00
 
 
Net Income-3.4M-3.7M-1.7M-2.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS281.5K295.3K395.9K76.1K
 
 
 
 
 
Shares To Calculate EPS Diluted281.5K295.3K395.9K76.1K
 
 
 
 
 
 
Earnings Per ShareEPS-$12.00-$12.60-$4.20--
 
 
 
 
EPS Diluted-$12.00-$12.60-$4.20-$33.00
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account